Navigation Links
Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison
Date:4/29/2009

COMMACK, N.Y., April 29 /PRNewswire-FirstCall/ -- It is with great privilege that Avery Biomedical Devices, Inc. (ABD) announces the appointment of Abbott Krieger, M.D., F.A.C.S. as Chief Clinical Liaison.

Dr. Krieger's expertise with Avery breathing pacemakers began in 1981 while he was Chief of Neurological Surgery at the University of Medicine and Dentistry of New Jersey. Based on that initial experience, Dr. Krieger went on to pioneer the reinnervation of the diaphragm through the use of intercostal to phrenic nerve grafts. He reported the first successful use of the technique in Neurosurgery in October, 1994. As a visiting professor, Dr. Krieger has traveled extensively around the world attending grand rounds and assisting other physicians in the development of their local diaphragm pacing programs.

Dr. Krieger most recently served as Clinical Professor in the Department of Neurological Surgery at the USC Keck School of Medicine in Los Angeles. He is currently in private practice in Beverly Hills, CA. As Chief Clinical Liaison, Dr. Krieger will lecture about the indications and latest advances in diaphragm pacing, and be available for clinical discussions regarding potential candidates for the breathing pacemaker.

Linda Towler, CEO, states, "We are honored to have Dr. Krieger join our team. His experience and expertise will be an invaluable addition to the future growth of ABD."

ABOUT ABD

Avery Biomedical Devices, Inc. (ABD) is a privately-held biomedical device manufacturer located on Long Island, New York. It produces the breathing pacemaker: an implanted phrenic nerve stimulator which is used to free many quadriplegic and central hypoventilation patients from mechanical ventilation. Through its affiliate, Avery Custom Devices, Inc., ABD manufactures high-quality platinum contact electrodes for research projects, clinical trials and commerci
'/>"/>

SOURCE Avery Biomedical Devices, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report
2. Abbott Annual Meeting Highlights Outstanding 2008 Results, Continued Strong Outlook
3. Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009
4. Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
5. Abbott Hosts Conference Call for First-Quarter Earnings
6. Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
7. Abbott to Present at Cowen Annual Health Care Conference
8. Abbott Announces Required Offer to Repurchase Convertible Senior Subordinated Notes of Its AMO Subsidiary
9. Abbott Completes Acquisition of Advanced Medical Optics
10. Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore
11. Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... Mass., Nov. 30 Harrington Physici...ion of Family Practice physicians Martin Devine, L...ts Charlton practice. ,, These four esteemed ... the Fallon Clinic, will soon join the Harrington ...n medical office building under construction at 10...
(Date:11/30/2009)...INNEAPOLIS, Nov. 30 The Eject Helm...ow required equipment in the Top Fuel, Funny Car, ...the National Hot Rod Association (NHRA) Full Throt... dragster and Top Alcohol Funny Car drivers in the... only product that allows medical caregivers at ra...
(Date:11/30/2009)...ears of development and extensive discussion in th...and Efficiency in Health Care (IQWiG) presents its...and benefit. The Institute can now apply these met...y the Federal Joint Committee (G-BA). The method d...mendations to the GKV-Spitzenverband [National Ass...
(Date:11/30/2009)...rt safe transplant results in animals , ,...udies in animals suggest that stem cells from tran...help treat some lung and heart disorders. , Sc...ferentiate into a long list of different kinds of ...Samsung Medical Center in Seoul, Korea, co-author ...
(Date:11/30/2009)...W YORK, Nov. 30 Reportlinker.com a...lable in its catalogue: ,, The Future of Senio... targeted opportunities for older consumers ,,...of-Senior-Nutrition-Key-ingredients-strategic-issu...html ,, Seniors, have emerged as a powerful co...
Breaking Medicine News(10 mins):Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3Health News:National Hot Rod Association Mandates Eject Helmet Removal System for 2010 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 4Health News:IQWiG presents a method for evaluating the relation between cost and benefit 5Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 2Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 3Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 4Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 5Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 6Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 7Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 8
... According to the research conducted by the scient...as found that mutation and loss of tumor suppresso...hers have used mouse models to determine the reaso...ation called Bcr-Abl and the loss of both copies o...
... Over 100 people in Ratlam in Madhya Pradesh fell ...d such incident in five days in the district, poli...e were admitted to Ratlam district hospital, the r...many of those admitted to hospital are gastroenter...
... The drug Zofran, commonly given in children to li...dehydrated by viral gastroenteritis //. A latest s... emergency room doctors are overusing the drug. ...n electrolyte solution for restoration of fluid el...
... Following detection of Alzheimer's disease in a f... survey calls for further testing of people // who...poisoning in 1988. The suggestion has been made in...the issue. The flow of nearly 20 tonnes aluminium ...
... According to an Irish researcher, frequent hiccup...lowing may be an indication of esophageal cancer. ..., from the James Connolly Memorial Hospital in Dub...orts foodconsumer.org. Six percent of patie...
... Transplant experts in Britain have accused China ...ling them without prior consent of the prisoners a...dence, which highlights that organs from executed ...he number of organs harvested from prisoners is cu...
Other Medicine News:Health News:Mouse Models To Determine The Cause Of Aggressive Leukemia 2Health News:Mouse Models To Determine The Cause Of Aggressive Leukemia 3Health News:GlaxoSmithKline's Zofran Helps In Treatment Of Dehydration In Children 2Health News:Call For Testing Of Poisoned Town: Risk Of Alzheimer's Disease 2Health News:Executed Prisoner Organs For Sale In China: BTS Concerned 2
(Date:11/30/2009)...L, Wash., Nov. 30 SCOLR ...at on November 25, 2009, the NYSE Amex LLC (the "E...d the Company,s plan to comply with its previously...)(iv) of the Exchange Company Guide. Specifically...stained losses which were so substantial in relati...
(Date:11/30/2009)...STON, S.C., Nov. 30 The Eleventh A...", will be held at the Charleston Place Hotel in t...r 3-4, 2009. Dr. Cheryl Liljestrand, Dr. Harry Gu...s with Stipkala LLC, will attend. SEBIO 2009 prom...nvestors, scientists, entrepreneurs, and service p...
(Date:11/30/2009)...W YORK, Nov. 30 Reportlinker.com a...lable in its catalogue: ,, Cardiac Defibrillat..., http://www.reportlinker.com/p0164315/Cardiac-De...ort.html ,, Cardiovascular disease (CVD) is o...den cardiac arrest survivors are prone to arrhythm...
Breaking Medicine Technology:SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 1International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 2International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 3International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 4International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 5International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 6International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 7Sage Software Healthcare Inc Celebrates National Health Center Week 54311 1Sage Software Healthcare Inc Celebrates National Health Center Week 54311 2Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 1Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 2
...S WIRE)--Apr 14, 2007 - In a late-breaker,presenta...sociation,for the Study of the Liver (EASL), resea... analysis of the PROVE 1 clinical trial,which is ... with,the investigational hepatitis C protease inh...h pegylated interferon (peg-IFN) and,ribavirin (RB...
...RNewswire-FirstCall/ -- ACCESS,PHARMACEUTICALS, IN...mechanism of ProLindac,s anticancer activity will ... Cancer Research (AACR) 2007,annual meeting in Los... two poster presentations describe preclinical stu...inent institutes in France. , "We are delighted to...
Other Medicine Technology:Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 2Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 4Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 6Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 7Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 8Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 2Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 3Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 4
Silicone Wedge (137 Style)
Silicone Tire (281 Style)
Silicone Strip (225 Style)
Silicone Boat (60 Style)
Medicine Products: